← FDA Drug Approvals (Drugs@FDA)

RAZADYNE

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2001-06-22

Drug application

FDA Application #

NDA021224

Application type

New Drug Application

Brand name

RAZADYNE

Generic name

Galantamine Hydrobromide

Active ingredients

GALANTAMINE HYDROBROMIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

JANSSEN PHARMS

First approval

2001-06-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown